Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Hepato-Biliary

No studies found 3 · 75%GRADE not reported 0 · 0%Very low 1 · 25%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Mortality at maximal · people with primary biliary cholangitis

It is very uncertain whether ciclosporin changes mortality at maximal compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
OR 0.88 [0.51, 1.5]
3 studies · 390 participants
Very low

Serious adverse events (proportion) · people with primary biliary cholangitis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events (number of events) · people with primary biliary cholangitis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Health‐related quality of life · people with primary biliary cholangitis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found